Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
33,235,472
-
Total 13F shares
-
14,430,601
-
Share change
-
+1,058,285
-
Total reported value
-
$109,095,635
-
Put/Call ratio
-
1.1%
-
Price per share
-
$7.56
-
Number of holders
-
51
-
Value change
-
+$4,457,712
-
Number of buys
-
33
-
Number of sells
-
34
Institutional Holders of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) as of Q2 2024
As of 30 Jun 2024,
NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,430,601 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, MORGAN STANLEY, Soleus Capital Management, L.P., Kent Lake Capital LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., DEUTSCHE BANK AG\, Nantahala Capital Management, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.